A new targeted therapy for hard-to-treat chronic lymphocytic leukemia appears to have fewer side effects than a previous therapy.
Andrea Califano and his investigative team discover a molecular signaling mechanism underlying a specific type of highly aggressive breast cancer.
In their new study, Guohua Li and Ruth Landau found a decreased rate of anesthesia-related complications in women who had cesarean delivery.
A Mailman study found that smokers who continue to smoke after treatment for alcoholism are at a greater risk of relapsing.
Mailman researcher Mark Hatzenbuehler finds new anti-bullying legislation has been effective in reducing bullying.
P&S neurosurgeon Adam Sonabend is awarded an NIH Early Independence Award for his research on brain tumors.
Mailman researchers examine the effects of prenatal exposure to PBDEs, a chemical found in common flame retardants, on children's development.
Celebrates acknowledges faculty, staff, and students at CUMC who receive major research grants or earn prestigious honors, as well as gifts made by donors.
KEYTRUDA is an immunotherapy that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2, helping the immune system to help detect and fight cancer cells.
Drugs like Prozac relieve symptoms of depression by acting on mature cells in a part the brain's hippocampus, a new study by René Hen shows.
Wendy Chung is part of a team that found commonalities in neuronal behavior between spinal muscular atrophy and ALS.